openPR Logo
Press release

Pharmacovigilance Market Research to be the Fastest Growing Segment in the Drug Discovery Market

12-21-2016 01:11 PM CET | Health & Medicine

Press release from: Global Market Insights Inc.

Global Market Insights, Inc.

Global Market Insights, Inc.

U.S. Pharmacovigilance Market size was valued over USD 1 billion in 2015, and predicted to witness 10.7% CAGR from 2016 to 2024 to surpass USD 2.5 billion by 2024. Rising mortality rates owing to adverse drug events and growing patient concerns pertaining to safety and efficacy of drugs will drive industry growth.

The Pharmacovigilance Market is rising as drugs has driven the need for new drug development through clinical trials. Pharmaceutical companies are collaborating with CROs to streamline R&D, medical writing, manufacturing operations, clinical data management and other pharmacovigilance activities to achieve greater efficiency at reduced cost. Outsourcing should enable better regulatory compliance, higher productivity and improved strategic outcomes spurring pharmacovigilance market growth.

Request for a sample of this research report - http://bit.ly/2hbc1nD

Furthermore, growing geriatric population base is associated with increased drug consumption for treatment of chronic diseases such as diabetes, oncology cardiovascular and respiratory disorders. Pharmacovigilance Market size is expected to exceed USD 8 billion by 2024; according to a new research report by Global Market Insights, Inc.

Increasing number of National pharmacovigilance centers across the globe along with rising patient awareness regarding adverse drug events will stimulate global pharmacovigilance market growth. However, lack of skilled professionals and risk associated with data security and web-based drug sales will hamper business expansion.

The phase IV clinical trial market size was valued more than USD 2 billion in 2015 and is expected to grow at over 10% by 2024. Phase IV studies ensure that restrictions could be imposed on a drug being sold depending on its safety performance.

Contract outsourcing market size was valued over USD 1 billion in 2015, poised to grow at 12.2% from 2016 to 2024 and surpass USD 4 billion by 2024. Contract outsourcing reduces overall economic losses linked with drug approval delays and trial failures. It is widely opted by companies to avoid huge investments and delegate such activities to specialized firms in this area.

U.S. pharmacovigilance market size was valued at more than USD 1 billion in 2015, with expectations to grow at 10.7% over the forecast period, owing to favorable governmental regulations, huge clinical trial volume and presence of large scale research companies. Additionally, growing patient concerns related to the drug safety and rising adverse drug events related mortality rates will positively impact pharmacovigilance market share.

Make an inquiry for purchasing this report @ http://bit.ly/2iedhm0

Spain pharmacovigilance market size was valued over USD 230 million in 2015 and should witness 10.2% CAGR from 2016 to 2024, to surpass USD 550 million by 2024. Rising demand for new drug development, growing geriatric population and increasing outsourcing by pharmaceutical companies should fuel regional industry growth. India pharmacovigilance market growth was more than 14% from 2016 to 2024, and expected to reach USD 668 million by 2024. The strong and robust growth is attributed to increasing number of clinical trials conducted across Asian countries, owing to low cost trial advantage over developed countries.

Key industry players such as Quintiles offer literature monitoring, safety aggregate reporting, benefit risk management, analytics and signal detection services. Synowledge offer signal detection services, which help clinical experts determine medical significance with the use of hi-tech visualization techniques.

Many industry participants are focusing on outsourcing pharmacovigilance services as a feasible cost reduction avenue. Outsourcing helps achieve better pharmacovigilance through regulatory compliance, better quality, enhanced productivity and improved strategic outcomes.

Browse key industry insights spread across 111 pages with 66 market data tables & 6 figures& charts from the report, “Pharmacovigilance Market Size By Clinical Trial Phase (Preclinical, Phase I, Phase II, Phase III, Phase IV), By Service Provider (In-house, Contract outsourcing) Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Spain, Italy, France, China, Japan, India, Australia, Argentina, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Qatar), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024” in detail along with the table of contents:

http://bit.ly/2i8RiRE

Key insights from the report include:

Europe pharmacovigilance market size was over USD 790 million in 2015 growing at anticipated close to 10% CAGR. Germany, UK, Spain together contributed for over 70% of regional pharmacovigilance market share in 2015.

Brazil pharmacovigilance market share was more than 60% of regional revenue for 2015, with target slated to exceed USD 300 million by 2024. South Africa pharmacovigilance market size was more than USD 37 million and anticipated for over 5% growth.

Phase III clinical trial market size was more than USD 450 million in 2015, with expectations to grow over 10% CAGR, due to increasing requirement for drug safety monitoring and evaluation.

Contract outsourcing held more than 50% of pharmacovigilance market share with target market size of over USD 1.7 billion in 2015. Increasing outsourcing trend adopted by pharmaceutical companies will serve as a high impact driver for the business growth.

Global pharmacovigilance market will be driven by collaboration between pharmaceutical companies and contract research organizations (CROs). The key industry participants include Accenture, Quintiles, Cognizant Technology Solutions, Boehringer Ingelheim, Covance, PAREXEL International Corporation, Bristol-Myers Squibb, Janssen Research & Development, Synowlwedge, United BioSource Corporation and ICON.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

29L Atlantic Avenue,
Suite L 105, Ocean View,
Delaware 19970
United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacovigilance Market Research to be the Fastest Growing Segment in the Drug Discovery Market here

News-ID: 399711 • Views: 365

More Releases from Global Market Insights Inc.

Steam Autoclaves Market | Insights and Forecast Research Report 2024
The steam autoclave market size is expected to exceed more than US$ 3.1 Billion by 2024, Growing at a CAGR of more than 8.7% in the given forecast period. The extensive use of sterilizing surgical equipment in pharmaceutical and biomedical applications has been propelling steam autoclaves market share over the last few years. The primary reason for the massive deployment of these products in medical applications is the nontoxic and
Advanced Wound Care Market 2019 | Growth, Status and Forecast by 2025
The global advanced wound care market size is expected to reach USD 13.5 billion by 2025, at a CAGR of 5.0% during the forecast period, according to a new report by Global market insights, Inc. Europe advanced wound care market will experience 5.0% growth during the analysis period. Germany, UK, and France represents mature markets in Europe while Spain, Netherland, Belgium, Austria are forecasted to witness high CAGR. Aging demographics
Vascular Graft Market | Industry Analysis, Size, Share, Growth by 2024
Vascular graft market size is anticipated to exceed US$ 3.6 bn by 2024, states Global Market Insights, Inc. in its latest research report. Prominent industries involved in vascular graft market are Becton Dickinson (C.R. Bard), B. Braun, Cryolife (Jotec), Cook Medical, Endologix, Getinge AB, LeMaitre Vascular, Medtronic PLC, Terumo GmbH and W.L. Gore and Associates. These prominent business players are focusing on strategic mergers, new product launch and acquisitions to
Pharmacovigilance Outsourcing Market 2019 | Dynamics, Forecast, Analysis and Sup …
U.S. pharmacovigilance outsourcing market size dominated North America region and was valued at USD 783.2 million revenue in 2017 and is estimated to witness similar trend during the forthcoming years. The high growth is attributed to strong foothold of major pharma and medical device companies coupled with extensive drug development activities in the U.S. Moreover, high healthcare expenditure in the country and growing concern regarding drug safety and adverse drug

All 5 Releases


More Releases for USD

Agriculture Robots worth USD 3.5 billion market
According to Goldstein Research, the rising demand for agriculture robots is being driven by a numerous factors including global population growth, increasing strain on the food supply and decreasing availability of farm workers in developed countries. Global agriculture robots market segmentation includes products types such as driverless tractors, milking robots, potato sorting system, unmanned aerial vehicles and other. The market for agricultural robots is emerging at a rapid pace, with
Polyurethane Dispersions Market worth USD 2.04 Billion USD by 2020
The report " Polyurethane Dispersions Market by Type (Water-Based Polyurethane Dispersions and Solvent-Based Polyurethane Dispersions), by Application (Coatings, Adhesives & Sealants, Synthetic Leather Production, Fiber Glass Sizing, and Others) - Trends & Forecasts to 2020", The global polyurethane dispersions market is projected to reach USD 2.04 Billion by 2020 at a CAGR of 6.8% between 2015 and 2020. This growth is fueled by the high potential from the textile and
Retail Analytics Market worth USD 5.1 Billion USD by 2020
According to a new market research report "Retail Analytics Market by Business Function (Marketing and Customer Analytics, Merchandizing and In-Store Analytics, Supply Chain Analytics, Strategy and Planning), by Type, by Solutions and by Services - Global Forecast and Analysis to 2020", defines and segments the global retail analytics market on the basis of business function, solutions, services, deployment types, and regions along with providing an in-depth analysis and market size
Metabolomics Market USD 1.24 Billion by 2020
The global metabolomics market is estimated to reach USD 1.24 Billion in 2020, growing at a CAGR of 15.6% from 2016 to 2020, according to a market research report Metabolomics Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Metabolomics Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/metabolomics-market/ Metabolomics is the scientific study of chemical processes involving metabolites, whereas metabolome represents the collection of all metabolites in a biological cell, tissue, organ or organism, which
Albumin Market USD 300 Million by 2020
According to a market research report Albumin Market 2013-2020, published by iHealthcareAnalyst, Inc., the global albumin market is estimated to reach USD 300 Million in 2020, expanding at a CAGR of 2.4% from 2016 to 2020. Visit the Albumin Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/albumin-market/ The global albumin market segmentation is based on type (human serum albumin, bovine serum albumin, recombinant albumin), and its applications (drug formulation and drug delivery, vaccines, components
Nanomedicine Market USD 170 Billion by 2020
The global nanomedicine market is estimated to reach USD 170 Billion in 2020, growing at a CAGR of 8.9% from 2016 to 2020, according to a market research report Nanomedicine Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Nanomedicine Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/nanomedicine-market/ Nanomedicine is the medical application of nanotechnology that ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of